Ildong Holdings Co., Ltd. (KRX:000230)

South Korea · Delayed Price · Currency is KRW

6,470.00

-100.00 (-1.52%)

Last updated: Sep 1, 2026, 1:06 PM KST

-29.83% (1Y)

Market Cap	74.19B -28.7%
Revenue (ttm)	607.65B +0.1%
Net Income	21.66B -63.3%
EPS	1,897.17 -59.9%
Shares Out	11.29M
PE Ratio	3.50
Forward PE	n/a
Dividend	100.00 (1.59%)
Ex-Dividend Date	Mar 30, 2026

Volume	2,906
Open	6,570.00
Previous Close	6,570.00
Day's Range	6,400.00 - 6,570.00
52-Week Range	5,450.00 - 17,170.00
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1941

Employees 72

Stock Exchange Korea Stock Exchange

Ticker Symbol 000230

Full Company Profile

Financial Performance

In 2025, Ildong Holdings's revenue was 590.89 billion, a decrease of -6.90% compared to the previous year's 634.65 billion. Earnings were 10.93 billion, a decrease of -82.67%.

Financial Statements